Document is current
Any future updates will be listed below
-
Authors
Ancoli-Israel, Sonia https://orcid.org/0000-0002-0662-8865
Liu, Lianqi
Natarajan, Loki
Rissling, Michelle
Neikrug, Ariel B.
Youngstedt, Shawn D.
Mills, Paul J.
Sadler, Georgia R.
Dimsdale, Joel E.
Parker, Barbara A.
Palmer, Barton W.
-
Funding
Funding for this research was provided by:
National Cancer Institute (CA112035)
National Institutes of Health (UL1RR031980)
U.S. Department of Veterans Affairs (CESAMH)
- License Information
-
More Information
Article History
Received: 13 May 2021
Accepted: 3 December 2021
First Online: 26 December 2021
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of UCSD and with the 1964 Helsinki Declaration and its later amendments. The study was approved by the UCSD Office of IRB Administration and by the UC San Diego Moores Cancer Center’s Protocol Review and Monitoring Committee.
: All participants provided written informed consent before participation.
: Participants consented to publication of results which did not include the identity of any individual participant.
: SAI is a consultant for Eisai, Biogen, Idorsia, Merck, and Pear Therapeutics. The other authors have no relevant financial or non-financial interests to disclose.
